Wikidata

(Q95389727)

English

Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL)

scientific article published in February 2014

In more languages

Statements

title
Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24870874
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870874%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 May 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q95389727&oldid=1713788451"